Benjamin Weinberg, MD, FACP

Dr. Weinberg is a medical oncologist, specializing in the treatment of patients with gastrointestinal
cancers. He received his undergraduate degree in biomedical science at the University of
Pennsylvania and his medical degree at the Keck School of Medicine of the University of
Southern California. He completed post-graduate medical training in internal medicine,
hematology, and oncology at MedStar Georgetown University Hospital. He is interested in
developing new therapies for colorectal and pancreatic cancers by translating research from
animal models into early phase clinical trials in humans.
He is also interested in studying young patients with colorectal cancer to understand the
dramatic rise in incidence of left-sided colon and rectal cancers in this population. His studies
compare the molecular signatures between left- and right-sided colorectal cancers and between
young and older patients with colorectal cancer. He also seeks to understand how gut bacteria
are impacting the rise of colorectal cancer in young people.
Throughout his medical career, Ben has worked exhaustively ensure patients are heard and
receive the highest quality of care. His training at Georgetown leads him in the pursuit of cura
personalis (“care for the whole person”), and he brings this mindset every day into the clinic and
all his work with patients.
Financial relationships
-
Attribution:SelfType of financial relationship:Professional ServicesIneligible company:RegeneronDate added:07/30/2024Date updated:07/30/2024
-
Attribution:SelfType of financial relationship:Professional ServicesIneligible company:AgenusDate added:07/30/2024Date updated:07/30/2024
-
Attribution:SelfType of financial relationship:Professional ServicesIneligible company:SeagenDate added:07/30/2024Date updated:07/30/2024
-
Attribution:SelfType of financial relationship:Professional ServicesIneligible company:MerusDate added:07/30/2024Date updated:07/30/2024
-
Attribution:SelfType of financial relationship:Professional ServicesIneligible company:Foundation MedicineDate added:07/30/2024Date updated:07/30/2024
-
Attribution:SelfType of financial relationship:Professional ServicesIneligible company:TaihoDate added:07/30/2024Date updated:07/30/2024
-
Attribution:SelfType of financial relationship:Professional ServicesIneligible company:SirtexDate added:07/30/2024Date updated:07/30/2024
-
Attribution:SelfType of financial relationship:Professional ServicesIneligible company:PrimumDate added:07/30/2024Date updated:07/30/2024
-
Attribution:SelfType of financial relationship:Professional ServicesIneligible company:DoMore DiagnosticsDate added:07/30/2024Date updated:07/30/2024
-
Attribution:SelfType of financial relationship:Professional ServicesIneligible company:BayerDate added:07/30/2024Date updated:07/30/2024